p15INK4b isoform 2 Antibody | 43-343

p15INK4b isoform 2 Antibody | 43-343 | Gentaur UK, US & Europe Distribution

Host: Goat

Reactivity: Human

Homology: N/A

Immunogen: The immunogen for this antibody is: C-RQGARERGARP

Research Area: Apoptosis, Cancer, Cell Cycle

Tested Application: E, WB

Application: Peptide ELISA: antibody detection limit dilution 1:128000.Western Blot:Approx 12+14kDa bands observed in Human Gastrointestinal cancer lysates (calculated MW of 8.1kDa according to NP_511042.1) . The observed 14kDa cannot represent isoform 1 and therefore it most likely represents another posttranslational modification of isoform 2. Recommended concentration: 1-3ug/ml.

Specificiy: This antibody is expected to recognize isoform 2 (NP_511042.1) only.

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: Approx 12 + 14kDa

Validation: N/A

Isoform: N/A

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Clonality: Polyclonal

Clone: N/A

Isotype: N/A

Conjugate: Unconjugated

Physical State: Liquid

Buffer: Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20��C. Minimize freezing and thawing.

Concentration: 500 ug/mL

Storage Condition: Aliquot and store at -20˚C. Minimize freezing and thawing.

Alternate Name: CDKN2B, cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) , CDK4I, INK4B, MTS2, P15, TP15, p15INK4b, CDK inhibitory protein, CDK4B inhibitor, MTS-2, cyclin-dependent kinase 4 inhibitor B, cyclin-dependent kinases 4 and 6 binding protein, multiple tumor suppressor 2, p14-INK4b, p14_CDK inhibitor, p14_INK4B, p15 CDK inhibitor, p15-INK4b, p15_INK4B

User Note: N/A

BACKGROUND: N/A